Organization
CHU de Rouen - Hôpital Charles-Nicolle
1 abstract
Abstract
Lacutamab in patients with relapsed and/or refractory mycosis fungoides: Results from the TELLOMAK phase 2 trial.Org: Hôpital Saint Louis, Multidisciplinary Cutaneous Lymphoma Program, Rochester Skin Lymphoma Medical Group, CHU de Rouen - Hôpital Charles-Nicolle, Universitair Ziekenhuis Leuven,